First Time Loading...

Fusion Pharmaceuticals Inc
NASDAQ:FUSN

Watchlist Manager
Fusion Pharmaceuticals Inc Logo
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Watchlist
Price: 21.4575 USD 0.03% Market Closed
Updated: May 6, 2024

Income Statement

Earnings Waterfall
Fusion Pharmaceuticals Inc

Revenue
2.1m USD
Operating Expenses
-101.3m USD
Operating Income
-99.2m USD
Other Expenses
4.3m USD
Net Income
-94.9m USD

Income Statement
Fusion Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
1
N/A
1
+63%
1
+69%
2
+41%
2
+2%
2
-8%
1
-24%
1
-38%
0
-59%
2
+497%
2
-6%
Operating Income
Operating Expenses
(16)
(26)
(38)
(47)
(67)
(77)
(83)
(87)
(79)
(83)
(90)
(93)
(100)
(98)
(101)
Selling, General & Administrative
(8)
(14)
(21)
(23)
(26)
(27)
(27)
(29)
(30)
(30)
(31)
(31)
(31)
(31)
(31)
Research & Development
(8)
(12)
(17)
(24)
(41)
(50)
(56)
(58)
(49)
(53)
(59)
(62)
(69)
(67)
(70)
Operating Income
(16)
N/A
(26)
-64%
(38)
-44%
(47)
-24%
(67)
-43%
(76)
-14%
(82)
-8%
(85)
-3%
(77)
+9%
(81)
-6%
(88)
-8%
(92)
-5%
(100)
-8%
(95)
+4%
(99)
-4%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
1
1
0
(1)
(2)
(2)
0
3
4
Total Other Income
(39)
(39)
(38)
(37)
1
1
0
1
0
0
1
0
0
0
1
Pre-Tax Income
(55)
N/A
(65)
-19%
(76)
-17%
(83)
-10%
(65)
+21%
(75)
-14%
(81)
-9%
(84)
-3%
(77)
+8%
(82)
-7%
(89)
-9%
(94)
-5%
(99)
-6%
(92)
+7%
(94)
-2%
Net Income
Tax Provision
(0)
(0)
(3)
(3)
(2)
(3)
0
0
1
2
2
2
1
1
(1)
Income from Continuing Operations
(55)
(65)
(78)
(86)
(68)
(77)
(81)
(83)
(76)
(80)
(88)
(92)
(98)
(91)
(95)
Net Income (Common)
(56)
N/A
(66)
-18%
(80)
-20%
(86)
-7%
(68)
+21%
(77)
-14%
(81)
-5%
(83)
-3%
(76)
+9%
(80)
-6%
(88)
-9%
(92)
-5%
(98)
-7%
(91)
+7%
(95)
-4%
EPS (Diluted)
-1.35
N/A
-1.59
-18%
-1.91
-20%
-2.05
-7%
-1.61
+21%
-1.79
-11%
-1.9
-6%
-1.94
-2%
-1.75
+10%
-1.85
-6%
-2
-8%
-1.71
+15%
-1.48
+13%
-1.32
+11%
-1.45
-10%

See Also

Discover More